Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?

Abstract

Although the use of non-myeloablative stem cell transplantation (NST) reduces the severity of graft-versus-host disease (GVHD), GVHD remains a major complication following allogeneic transplantation. Since following NST in comparison with myeloablative conditioning, higher proportions of host immunohematopoietic cells may persist while donor-derived alloreactive lymphocytes are being infused, thus possibly serving as host antigen presentation for continuous stimulation of donor T cells, we speculated that GVHD may be similarly amplified by conditioning followed by intentional administration of host cells. This hypothesis was tested in a preclinical animal model. Increased incidence of GVHD, higher mortality and increased levels of chimerism were observed in recipients reconstituted with host cells, particularly with non-irradiated spleen cells. Graft-versus-leukemia effect was not impaired by post transplant cell administration. These results suggest that GVHD may be amplified by recipient cell infusion using either irradiated or viable stimulatory host cells, thus possibly explaining in part higher than anticipated incidence of GVHD and rapid displacement of host cells and conversion to 100% donor type cells following NST. Administration of irradiated host antigen-presenting cells post transplantation may thus represent a potential approach for amplification of the alloreactive capacity of donor lymphocytes following stem cell transplantation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531–4536.

    CAS  PubMed  Google Scholar 

  2. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Non-myeloablative transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood 1998; 91: 756–763.

    CAS  PubMed  Google Scholar 

  3. Slavin S, Nagler A, Aker M, Shapira MY, Cividalli G, Or R . Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders. Rev Clin Exp Hematol 2001; 5: 135–146.

    Article  CAS  PubMed  Google Scholar 

  4. Slavin S, Fuks Z, Kaplan HS, Strober S . Transplantation of allogeneic bone marrow without graft vs host disease using total lymphoid irradiation. J Exp Med 1978; 147: 963–972.

    Article  CAS  PubMed  Google Scholar 

  5. Ildstad ST, Sachs DH . Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168–170.

    Article  CAS  PubMed  Google Scholar 

  6. Sykes M, Sachs DH . Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today 1988; 9: 23–27.

    Article  CAS  PubMed  Google Scholar 

  7. Couriel DR, Saliba RM, Giralt S, Khouri I, Andersson B, de Lima M et al. Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biol Blood Marrow Transplant 2004; 10: 178–185.

    Article  PubMed  Google Scholar 

  8. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J et al. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412–415.

    Article  CAS  PubMed  Google Scholar 

  9. Duffner UA, Maeda Y, Cooke KR, Reddy P, Ordemann R, Liu C et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 2004; 172: 7393–7398.

    Article  CAS  PubMed  Google Scholar 

  10. Chan GW, Gorgun G, Miller KB, Foss FM . Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 170–176.

    Article  PubMed  Google Scholar 

  11. Goker H, Haznedaroglu IC, Chao NJ . Acute graft-vs-host disease: pathobiology and management. Exp Hematol 2001; 29: 259–277.

    Article  CAS  PubMed  Google Scholar 

  12. Slavin S, Strober S . Spontaneous murine B-cell leukemia. Nature 1978; 272: 624–626.

    Article  CAS  PubMed  Google Scholar 

  13. Slavin S, Weiss L, Morecki S, Bassat HB, Leizerowitz R, Gamliel H et al. Ultrastructural, cell membrane and cytogenetic characteristics of B-cell leukemia (BCL1), a murine model of chronic lymphocytic leukemia. Cancer Res 1981; 41: 4162–4166.

    CAS  PubMed  Google Scholar 

  14. Pugatsch T, Weiss L, Slavin S . Minimal residual disease in murine B cell leukemia (BCL1) detected by PCR. Leukemia Res 1993; 17: 999–1002.

    Article  CAS  Google Scholar 

  15. Appelbaum FR, Thomas ED . Treatment of acute leukemia in adults with chemoradiotherapy and bone marrow transplantation. Cancer 1985; 55: 2202–2209.

    Article  CAS  PubMed  Google Scholar 

  16. Sinkovics JG, Shullenberger CC . Effect of hematopoietic chimerism on the course of Rauscher's viral mouse leukemia. Proc Am Assoc Cancer Res 1963; 4: 62–72.

    Google Scholar 

  17. Boranic M, Tonkovic I . Time pattern of the antileukemia effect of graft-vs-host reaction in mice. I. Cellular events. Cancer Res 1971; 31: 1140–1147.

    CAS  PubMed  Google Scholar 

  18. Weiden PL, Fluornoy N, Sanders JE, Sullivan KM, Thomas ED . Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. Transplantation 1981; 13: 248–251.

    CAS  Google Scholar 

  19. Slavin S, Or R, Naparstek E, Ackerstein A, Weiss L . Cellular-mediated immunotherapy of leukemia in conjunction with autologous and allogeneic bone marrow transplantation in experimental animals and man. Blood 1988; 72 (Suppl 1): 407a.

    Google Scholar 

  20. Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R . Allogeneic cell therapy for relapsed leukemia following bone marrow transplantation with donor peripheral blood lymphocytes. Exp Hematol 1995; 23: 1553–1562.

    CAS  PubMed  Google Scholar 

  21. Slavin S, Naparstek E, Nagler A, Ackerstein A, Samuel S, Kapelushnik J et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after post allogeneic bone marrow transplantation. Blood 1996; 87: 2195–2204.

    CAS  PubMed  Google Scholar 

  22. Ferrara JLM, Cooke KR, Pan L, Krenger W . The immunopathophysiology of acute graft-versus-host disease. Stem Cells 1996; 14: 473–489.

    Article  CAS  PubMed  Google Scholar 

  23. Weiss L, Slavin S . Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin. Bone Marrow Transplant 1999; 23: 1139–1143.

    Article  CAS  PubMed  Google Scholar 

  24. Rachamim N, Gan J, Segall H, Krauthgamer R, Marcus H, Berrebi A et al. Tolerance induction by ‘megadose’ hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 1998; 65: 1386–1393.

    Article  CAS  PubMed  Google Scholar 

  25. Prigozhina TB, Gurevitch O, Slavin S . Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice. Exp Hematol 1999; 27: 1503–1510.

    Article  CAS  PubMed  Google Scholar 

  26. Bittencourt MC, Perruche S, Contassot E, Fresnay S, Baron MH, Angonin R et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001; 98: 224–230.

    Article  CAS  PubMed  Google Scholar 

  27. Cohen P, Vourka-Karussis U, Weiss L, Slavin S . Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens. Immunol 1993; 151: 4803–4810.

    CAS  Google Scholar 

Download references

Acknowledgements

This work was carried out at the Danny Cunniff Leukemia Research Laboratory. We wish to thank the Gabrielle Rich Leukemia Research Foundation; the Cancer Treatment Research Foundation; the Novotny Trust; the Szydlowsky Foundation; The Fig Tree Foundation; Ronne & Donald Hess and the Silverstein Families for their continuous support of our basic and clinical research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Y Shapira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirshfeld, E., Weiss, L., Kasir, J. et al. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?. Bone Marrow Transplant 38, 359–364 (2006). https://doi.org/10.1038/sj.bmt.1705449

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705449

Keywords

Search

Quick links